PD-L1-Expression in primary and recurrent vulvar squamous cell cancer
PD-L1 expression in primary vulvar cancer is associated with poorer prognosis. Hence, PD-L1 is a possible target for immune checkpoint inhibitors and women might benefit from special treatment options.
Authors
- Nelson John
- Christian Matek (ORCID: https://orcid.org/0000-0001-8528-8581)
- Lothar Häberle
- Antje Knöll (ORCID: https://orcid.org/0000-0002-1294-6923)
- Leah-Sophie Leikauf
- Arndt Hartmann
- Matthias W. Beckmann
- Carol Geppert
- Frederik A. Stuebs
Institutions
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Universitätsklinikum Erlangen (DE)
- Comprehensive Cancer Center Erlangen (DE)
Publication Details
- Journal
- Gynecologic Oncology
- Published
- 2025-01-10
- DOI
- https://doi.org/10.1016/j.ygyno.2025.01.001
- Citations
- 3
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 3.14
Funders
- Friedrich-Alexander-Universität Erlangen-Nürnberg
- Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg